Process development optimization for GMP manufacturing: A CAR-T case study
Oct
6
2022
On demand

Process development optimization for GMP manufacturing: A CAR-T case study

Thursday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Process development optimization for GMP manufacturing: A CAR-T case study

Live30 webinars are thirty minute presentations designed to update you on the latest innovations, applications and data in a fast yet interactive format.

In this webinar, we will discuss the importance of PD optimization and some of the key considerations such as: choosing a partner for outsourcing PD projects, the timing needed for a typical PD project, technology and process transfer to GMP manufacturing, etc.

Finally, we will review a case study for Lentiviral manufacturing which is required upstream of an autologous CAR-T clinical trial. The duration, sequence and dependencies of these two distinct PD projects, and their subsequent GMP manufacturing campaigns, will be examined.

  • Understand the timing and planning process for a typical process development process to achieve GMP manufacturing.
  • Learn more about process development capabilities to support cGMP manufacturing.
  • Review a case study for Lentiviral manufacturing, supporting CAR-T.
Gary Pigeau PhD
Gary Pigeau PhD
Director of Research and Development, Nucleic Acid Therapeutics, Cytiva

SPEAKERS

Gary Pigeau PhD
Gary Pigeau PhD
Director of Research and Development, Nucleic Acid Therapeutics, Cytiva